WGRX (Wellgistics Health) EBITDA Margin %: -340.58% (As of Mar. 2026)


What is Wellgistics Health EBITDA Margin %?

Wellgistics Health WGRX -2.93% EBITDA Margin % is -340.58% as of Mar. 2026. The stock has 6 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Wellgistics Health ranks worse than 96.23% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Wellgistics Health's EBITDA for the three months ended in Mar. 2026 was $-5.31 Mil. Wellgistics Health's Revenue for the three months ended in Mar. 2026 was $1.56 Mil. Therefore, Wellgistics Health's EBITDA margin for the quarter that ended in Mar. 2026 was -340.58%.

Wellgistics Health  (NAS:WGRX) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Wellgistics Health EBITDA Margin % Related Terms

Wellgistics Health EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Wellgistics Health's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wellgistics Health EBITDA Margin % Chart

Wellgistics Health Annual Data
Trend Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
-1.13 0.00 -27.08 -400.57

Wellgistics Health Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -281.08 -60.15 -1,065.05 -1,566.43 -340.58

WGRX vs HEWA, BLMH, PMHS: EBITDA Margin % Comparison

For the Pharmaceutical Retailers subindustry, Wellgistics Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wellgistics Health EBITDA Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Wellgistics Health's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Wellgistics Health's EBITDA Margin % falls into.


Wellgistics Health EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Wellgistics Health's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-93.484/23.338
=-400.57 %

Wellgistics Health's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-5.313/1.56
=-340.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -340.58% mean?
Wellgistics Health (WGRX) has a EBITDA Margin % of -340.58% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Wellgistics Health and its competitors. According to the industry distribution chart, Wellgistics Health ranks #639 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 96.2%.
Is Wellgistics Health's EBITDA Margin % too high?
Wellgistics Health's current EBITDA Margin % is -340.58%. Based on the distribution chart, Wellgistics Health ranks #639 out of 664 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Wellgistics Health's EBITDA Margin % compare to HEWA and BLMH?
According to the Healthcare Providers & Services industry distribution chart, Wellgistics Health ranks #639 out of 664 companies for EBITDA Margin %. This places Wellgistics Health in the lower half of its industry. The industry median EBITDA Margin % is 10.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Wellgistics Health and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wellgistics Health's current EBITDA Margin % is -340.58%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wellgistics Health stock overvalued right now?
Wellgistics Health (WGRX) has a current EBITDA Margin % of -340.58%. The current EBITDA Margin % is -340.58%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Wellgistics Health (WGRX), the current EBITDA Margin % is -340.58% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Wellgistics Health Business Description

Address 3000 Bayport Drive, Suite 950, Tampa, FL, USA, 33607
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. The company seeks to be a micro health ecosystem, with a portfolio comprising a pharmacy, wholesale operations, and a technology division that provides a novel platform for hub and clinical services. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.